Pharmaceutical industry, as well as basic science, depend on robust data and scientific rigor for decision making, patent strength and time-to-market for novel patient treatment options. Recent publications challenge the quality of research data, which may impact translatability and predictability of preclinical models. There is a need for simple, sustainable solutions that improve data quality.
The objectives of EQIPD are to:
- enable the development of quality criteria for future preclinical tests
- develop consensus quality management recommendations in non-regulated R&D to enhance the quality of decisions made based on experimental, exploratory or hypothesis-testing data
- develop an educational course on scientific quality principles which catalyses the cultural change needed to enhance quality value and sustainability of the findings of preclinical research.
EQIPD Summer School 2018
September 10-14, 2018
Radboud university medical center, Nijmegen, The Netherlands
- Kim Wever
- Thomas Steckler
- Malcolm Macleod
- Martin Michel
- Anton Bespalov
- Martien Kas
- Lee Monk
- Judith van Luijk